Literature review July–September 2011

Authors


Andrew Stone, Clinical Development, AstraZeneca Pharmaceuticals, Alderley Park,Macclesfield, SK10 4TG, UK.

E-mail: Andrew.stone@astrazeneca.com

No abstract is available for this article.

Ancillary